Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion

doi:10.1016/j.ejso.2006.03.019

European Journal of Surgical Oncology (EJSO)

Volume 32, Issue 6, August 2006, Pages 619-624

https://doi.org/10.1016/j.ejso.2006.03.019 Get rights and content

Abstract

The new treatment strategy for Peritoneal Surface Malignancy combines a cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cytoreduction removes all macroscopic tumor. Intraperitoneal chemotherapy avoids implantation of microscopic residual tumor cells on intra-abdominal surfaces when it is administered intraoperatively and/or early in the postoperative period. Delivering cytotoxic drugs directly into the peritoneal cavity maximizes dose intensity and minimizes systemic toxicity. Hyperthermia is selectively cytotoxic for malignant cells and potentiates the effect of chemotherapy.

Implementation of this procedure makes the perioperative personnel to face a risk of exposure to cytotoxic agents. Furthermore, peritonectomies and electro-evaporation of tumor nodules are performed with high voltage electrocautery, generating a large amount of surgical smoke during several hours. Inhalation of these fumes may be also a risk for healthcare workers.

In this article, we analyse in depth these new risks of the operating room personnel, we review the literature, and we give guidelines for secure performance of cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy, as well as for early postoperative intraperitoneal chemotherapy administration.

These new procedures are safe techniques for patients and healthcare workers provided adequate policies are adopted to avoid occupational exposure.

Introduction

Many patients with Peritoneal Surface Malignancy (PSM) have criteria of loco-regional disease, without systemic dissemination. Consequently, a curative approach based on a dose intensification treatment in the abdominal cavity is rational. This new strategy combines maximal cytoreductive surgery (by peritonectomies, visceral resections and electro-evaporation of small tumor nodules) for the macroscopic disease and regional perioperative chemotherapy (hyperthermic intraoperative intraperitoneal chemotherapy – HIIC, with or without early postoperative intraperitoneal chemotherapy – EPIC) for the microscopic residual disease. Several phase II and phase III studies on the treatment of PSM using this combined strategy1, 2, 3, 4, 5 have shown a long-term survival in about 25% of the patients.

This innovative treatment strategy introduces cytotoxic drugs at the operating room for performing an intraperitoneal perfusion of hyperthermic chemotherapy during the operation. Cytotoxic agents are not commonly used by the operating room personnel. In addition, the way of administration, directly into the abdominal cavity; the time of applying, during the operation or immediately after; and the use of chemotherapy with hyperthermia (42–43°C), to maximize toxicity on tumor cells, are not the usual form of management of chemotherapy. All these novelties demand a new technology that has to be introduced into the operating room. Similarly, EPIC is administered in the Intensive Care Unit and the surgical ward where chemotherapy is not frequently used.

Healthcare workers involved in these new procedures have to face new risks of exposure to cytotoxic drugs. They must be fully informed, suitably educated and properly trained in order to perform cytoreduction, HIIC and EPIC safely.

Section snippets

Education as a safety factor

Operating room personnel is familiar to occupational hazards such as exposure to infectious diseases (HBV, HCV, HIV, TBC, …), exposure to ethylene oxide remains, inhalation of anesthetic gases, use of X rays, etc. Safety regulations adopted have made safe their work. Similarly, institutions implementing treatments based on cytoreduction and perioperative intraperitoneal chemotherapy must elaborate and write down specific guidelines for safe administration of cytotoxic drugs based on established

Electrocautery and surgical smoke

Cytoreductive surgery is achieved by peritonectomies of the parietal peritoneum, multiple visceral resections and electro-evaporation of tumor nodules on peritoneal surface (mesentery, Glisson capsule, small bowel wall, …).¹⁵ This surgical procedure is performed with electrocautery on pure cut, high voltage, with an extended insulated shaft of 10–15 cm, and a 3 mm ball tip,¹⁶ producing a large amount of surgical smoke. The procedure may take from 8 to 12 h, making prolonged exposure to surgical

Perioperative intraperitoneal chemotherapy

Handling the cytotoxic solutions: The chemotherapy solution is prepared in the Pharmacy Department, and is sent to the operating room in a closed light-protected bag which is handled with gloves checking integrity of the bag. Any leak detected makes the bag to be returned to the Pharmacy Department. If the bag is approved, there is no risk of direct exposure, and it is given to the person responsible for the perfusion.

Risk during HIIC administration: There are three methods for intraperitoneal

Personnel selection for cytoreduction and perioperative chemotherapy

Implementation of a Program of Treatment of Peritoneal Surface Malignancy makes the perioperative personnel to face a risk of exposure to cytotoxic agents and surgical smoke. Though cumulative effects of long-term, low-dose occupational exposure to cytotoxic agents have not been reported, institutional policies must be elaborated to protect patients and healthcare workers.

Participation in this procedure requires a personnel selection to avoid association with developing health problems in the

Guidelines for safe administration of HIIC

At the beginning of the operation, the surgical field should be arranged with impervious, disposable sheets and drapes, avoiding the use of any non-disposable fabric cloth.

Restriction of personnel inside the operating room: All personnel not actually involved in the administration of HIIC should leave the operating theater during the administration of chemotherapy.

Doors of the operating room should be closed and signs advising that HIIC is in progress must be placed at the entrance of the

Guidelines for safe administration of EPIC

Drains and inflow catheter are left in place once the procedure is finished. Immediate postoperative abdominal lavage is indicated. If the patient progress satisfactorily on the day after the operation, EPIC is administered at the UVI or at the surgical ward. Patient should be located in a single room with advising signs on the door about chemotherapy administration. The route of exposure is direct contact to the skin or mucous membranes. Use of standard protective universal precautions (eye

References (26)

D.M. Elias et al.
Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis
Surg Oncol Clin N Am
(2003)
S.K. White et al.
Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations
AORN
(1996)
T.H. Connor et al.
Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37°C using a desiccator technique
Mutat Res
(2000)
F.C. Storm
Clinical hyperthermia and chemotherapy
Radiol Clin North Am
(1989)
B. Hildebrandt et al.
The cellular and molecular basis of hyperthermia
Crit Rev Oncol/Hematol
(2002)
F.A. Zoetmulder et al.
Hyperthermic intraperitoneal chemotherapy with mitomycin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin
Proc Am Soc Clin Oncol
(2002)
V.J. Verwaall et al.
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
J Clin Oncol
(2003)
P.H. Sugarbaker
Successful management of microscopic residual disease in large bowel cancer
Cancer Chem Pharmacol
(1999)
C.R. Rossi et al.
Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis
Cancer
(2004)
A. Matsui et al.
Pharmacology of intraperitoneal CPT-11
Surg Oncol Clin N Am
(2003)

R.E. Yodaiken et al.

OSHA work practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational Safety and Health Administration

Am J Hosp Pharm

(1986)

Joint Comisión on Acreditation of Healthcare Organizations, Comprehensive accreditation Manual Hospitals 1995 (Oakbook...

G.M. Hahn et al.

Thermochemotherapy: synergism between hyperthermia and Adriamycin (or bleomycin) in mammalian cell inactivation

Proc Natl Acad Sci U S A

(1975)

Cited by (64)

High-frequency electric knife smoke particles: An experimental study on factors influencing emission characteristics
2024, Ecotoxicology and Environmental Safety
During surgery, the use of a high-frequency electric knife produces smoke, which can be harmful to the health of indoor medical staff and patients. The quantity and particle size distribution of smoke particles produced by different tissues may vary. Understanding the release characteristics of these smoke particles is necessary to clarify their impact on the surgical environment and to seek effective smoke control methods. A previous comparative analysis of human and pig tissues revealed that they share similar water and fat compositions in certain anatomical regions. In this study, we investigated the emission characteristics of smoke particles from various tissues of pigs (skeletal muscle, liver, kidney, skin, and subcutaneous fat) under different operating powers of an electric knife. We measured the indoor particle number concentration (particle concentration), and estimated the PM_2.5 mass concentration (PM_2.5 concentration), particle size distribution, and emission rate of the smoke particles. The study obtained the particle emission rates of different tissues under different electric knife operating powers, results of which showed that (1) during the operation of the electric knife, mainly small particles below 1 μm are produced. Among them, particles of 0.3 μm were the most abundant, with a particle concentration level of up to 10⁹ particles/m³, accounting for 85.17–97.64% of the total particle number, and as the particle size increased, the particle concentration and percentage decreased significantly. (2) The water and fat compositions of different tissues influenced the indoor particle concentration and emission rate of the smoke emitted by the electric knife. Among different tissues, subcutaneous fat tissue had the lowest particle concentration and emission rate. (3) The electric knife operating power mainly affected particles below 1 μm, and except for kidney tissue, the indoor concentration and emission rate of these particle sizes were positively correlated with the power. The experimental results can provide data reference for the use of high-frequency electric knives in surgeries involving different human tissues in the operating room.
Electrosurgery in dermatology
2021, Clinics in Dermatology
Electrosurgery applies high frequency alternating electrical currents to generate heat, thereby creating tissue damage required for cutting, hemostasis, or destruction. Electrosurgery can be delivered in a variety of different ways and can be tailored to achieve the desired clinical effect. Having a command of the underlying principles of electrosurgery will help dermatologic surgeons use the appropriate form of electrosurgery to safely achieve the desired results. We reviewed basic principles of electrosurgery, described the various techniques and devices, and delineated associated risks of electrosurgery for specific patient populations and providers. All modalities of electrosurgery present a risk of electromagnetic interference, which can negatively affect patients with implanted devices, such as pacemakers, defibrillators, cochlear implants, and deep brain stimulators. In particular, electrosurgery may create a smoke plume containing a number of volatile organic compounds potentially noxious; however, the risk of such exposure remains unknown.
Evaluation of exposure risk for healthcare personnel performing the open technique HIPEC procedure using cisplatin
2021, Gynecologic Oncology
Citation Excerpt :
The exposure to chemical agents for operators is a widespread concern among healthcare workers. Safety considerations have been taken into account since HIPEC was initially described, and have continued to grow with the increasing diffusion of this technique [12–15]. During the procedure of the open (‘coliseum’) technique with a ring tractor lifting the abdominal wall, the volume of perfusion injection and temperature increases, as does the contact area of the organ.
Objective: To perform an evaluation of the risk to healthcare personnel of exposure to cisplatin during a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedure in an operating room environment.
Methods: Breathing zone air samples were taken from the operating room (OR) before, during and after the procedure of HIPEC filter membrane adsorption and the liquid impact method was applied to collect air samples. The samples of surface wipe from the floor of the OR were taken after the procedure. Inductively coupled plasma mass spectrometry(ICP-MS) was used to detect the content of cisplatin in all the samples.
Results: Thirty-six air samples and three surface wipes were collected from three different locations of healthcare personnel breathing zones. All the breathing zone air samples were negative for cisplatin; however, cisplatin contamination was detected on three surface wipes from the floor, but in a lowconcentration(≤ 2.25 ng).
Conclusion: The results suggest that the risk of inhalation of cisplatin was extremely low for the healthcare personnel during the procedure of HIPEC, but the contamination of the OR floor should be taken into consideration.
Airborne particle emission rates and doses received in operating rooms from surgical smoke
2019, Building and Environment
Citation Excerpt :
The amount and composition of the surgery smoke emitted depends on several influential parameters including the type of surgery, the surgeon technique, the pathology of the target tissue, the type of energy imparted, the power levels used, and the amount of cutting, coagulation, or ablating performed [16–18]. The surgical smoke is composed of 95% water and 5% cellular debris in the form of particulate matter, which in turn is constituted by chemicals, blood and tissue particles, viruses, and bacteria [19]. The chemical composition of surgical smoke has been investigated in several papers [8–10,16,20,21].
The surgical smoke is commonly generated by electrosurgery, i.e. by the heat-producing device used in operating rooms for cutting tissues and coagulating small blood vessels through the use of high-frequency electrical current. Health effects due to the exposure to surgical smoke were recently recognized, thus the scientific community is currently paying more attention to such research field. In particular, studies focusing on the improvement of the effectiveness of filtration systems and mechanical ventilation systems were carried out, nonetheless, a gap of knowledge on the particle concentration levels in the operating rooms and on the emission rate of the surgical procedures still exists.
In the present paper an experimental analysis was performed (i) to estimate the particle emission per unit time for several types of surgery for different aerosol metrics and (ii) to measure the dose of both sub-micron and super-micron particles received by workers and patients. To this purpose, samplings were performed in seven operating rooms located in three different Italian hospitals.
The median emission rates in terms of particle number and mass concentrations amongst the surgery procedures investigated varied in the 1.59–3.21 × 10¹¹ part. min⁻¹ and 0.09–0.32 mg min⁻¹ ranges, respectively, leading to corresponding median particle concentration levels of 0.7–1.2 × 10⁴ part. cm⁻³ and 5–13 μg m⁻³.
Finally, the median particle surface area dose received by personnel working in the operating rooms during the surgery procedures varied from 5 to 12 mm².
Techniques and Safety Issues for Intraperitoneal Chemotherapy
2018, Surgical Oncology Clinics of North America
Citation Excerpt :
Eye protection should be worn as a mechanical barrier not just for the smoke, but also for cytostatic agents and bodily fluid exposure, as part of a universal precaution protocol. There are several recommended individual protective measures and environmental measures to minimize staff chemotherapy exposure during HIPEC22: Use of impervious, disposable surgical drapes; do not use textile cloth
Is hyperthermic intraperitoneal chemotherapy (HIPEC) safe for healthcare workers?
2017, Surgical Oncology
During hyperthermic intraperitoneal chemotherapy (HIPEC), caregivers are exposed by different routes to cytotoxic drugs. This review proposes an overview of the safety of HIPEC by assessing existing data on protection procedures, biological and non-biological samples. Based on these data, relevant good practices, eventual irrelevant overprotection procedures and missing data to implement adapted protections are highlighted.
Data were extracted from a systematic review of literature from 1980 till 2016: number and type of surgical procedure, healthcare professionals present, protective equipment, samples, pre-analytical method and analytical method.
Only 55 HIPEC procedures have been evaluated. The majority of antineoplastic drugs used have all required characteristics to penetrate the organism and are recognized as very dangerous. Moreover, a great heterogeneity in protective equipment used, either individual or collective is observed. Environmental contamination occurs during HIPEC, especially for all surfaces in the operating room. Compounds penetration into caregivers lungs cannot be excluded. Priority remains to prove professionals contamination by focusing on biological samples. Biological material is rarely sampled or samples are not necessarily adapted.
Repeated blood tests should be preferred using appropriate sampling schedules and validated sensitive analytical methods. Furthermore, there is a great need of new biological indicators to monitor caregivers exposure.
During hyperthermic intraperitoneal chemotherapy (HIPEC), healthcare workers are exposed by different routes to cytotoxic drugs. There are currently few available occupational exposure data and environmental monitoring and biomonitoring must be improved in order to ensure optimal protection against antineoplastic drugs.

View all citing articles on Scopus

¹: Tel.: +34 91 383 49 80; fax: +34 91 768 06 81.

View full text

Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion

Abstract

Introduction

Section snippets

Education as a safety factor

Electrocautery and surgical smoke

Perioperative intraperitoneal chemotherapy

Personnel selection for cytoreduction and perioperative chemotherapy

Guidelines for safe administration of HIIC

Guidelines for safe administration of EPIC

Surg Oncol Clin N Am

AORN

Mutat Res

Radiol Clin North Am

Crit Rev Oncol/Hematol

Hyperthermic intraperitoneal chemotherapy with mitomycin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin

Proc Am Soc Clin Oncol

Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer

J Clin Oncol

Successful management of microscopic residual disease in large bowel cancer

Cancer Chem Pharmacol

Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis

Cancer

Pharmacology of intraperitoneal CPT-11

Surg Oncol Clin N Am

OSHA work practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational Safety and Health Administration

Am J Hosp Pharm

Thermochemotherapy: synergism between hyperthermia and Adriamycin (or bleomycin) in mammalian cell inactivation

Proc Natl Acad Sci U S A